Total Payments
$2,068
2024 Payments
$39.71
Companies
13
Transactions
73
Medicare Patients
2,206
Medicare Billing
$151,559
Payment Breakdown by Category
Food & Beverage$2,036 (98.5%)
Education$31.62 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,036 | 71 | 98.5% |
| Education | $31.62 | 2 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $772.44 | 13 | $0 (2021) |
| GlaxoSmithKline, LLC. | $439.27 | 37 | $0 (2023) |
| Lilly USA, LLC | $248.43 | 5 | $0 (2020) |
| Radius Health, Inc. | $186.21 | 5 | $0 (2018) |
| Melinta Therapeutics, Inc. | $108.72 | 1 | $0 (2018) |
| Allergan, Inc. | $102.14 | 3 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $45.41 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $39.92 | 1 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $39.71 | 2 | $0 (2024) |
| Cardiovascular Systems Inc. | $32.72 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.71 | 2 | Bayer Healthcare Pharmaceuticals Inc. ($39.71) |
| 2023 | $47.53 | 2 | GlaxoSmithKline, LLC. ($31.80) |
| 2022 | $60.37 | 3 | GlaxoSmithKline, LLC. ($60.37) |
| 2021 | $250.34 | 12 | AstraZeneca Pharmaceuticals LP ($114.92) |
| 2020 | $199.23 | 16 | GlaxoSmithKline, LLC. ($127.95) |
| 2019 | $22.43 | 1 | Novartis Pharmaceuticals Corporation ($22.43) |
| 2018 | $519.72 | 20 | Radius Health, Inc. ($166.48) |
| 2017 | $928.27 | 17 | AstraZeneca Pharmaceuticals LP ($519.71) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Cardio-renal | ||||||
| 07/25/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: RESPIRATORY | ||||||
| 07/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: RESPIRATORY | ||||||
| 04/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: RESPIRATORY | ||||||
| 02/03/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $113.30 | General |
| Category: Respiratory | ||||||
| 10/08/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: RESPIRATORY | ||||||
| 08/31/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $1.62 | General |
| Category: Respiratory | ||||||
| 04/20/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: RESPIRATORY | ||||||
| 03/30/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: RESPIRATORY | ||||||
| 02/02/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/28/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: RESPIRATORY | ||||||
| 12/08/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2020 | Lilly USA, LLC | EMGALITY (Drug), TRULICITY | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 120 | 322 | $53,555 | $19,386 |
| 2022 | 8 | 281 | 484 | $61,672 | $20,235 |
| 2021 | 23 | 1,144 | 2,001 | $203,800 | $67,842 |
| 2020 | 20 | 661 | 1,518 | $137,021 | $44,096 |
Total Patients
2,206
Total Services
4,325
Medicare Billing
$151,559
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 238 | $39,270 | $13,276 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 57 | $9,965 | $5,157 | 51.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 27 | $4,320 | $953.40 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 237 | $40,473 | $12,801 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $6,188 | $3,068 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 34 | $8,230 | $2,503 | 30.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 18 | 26 | $4,160 | $1,213 | 29.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 75 | 103 | $1,045 | $308.40 | 29.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 22 | $616.00 | $167.53 | 27.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 13 | 14 | $630.00 | $90.32 | 14.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 17 | 24 | $330.00 | $83.28 | 25.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 174 | 411 | $72,931 | $24,461 | 33.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 101 | 178 | $44,872 | $14,264 | 31.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 83 | 125 | $21,865 | $6,664 | 30.5% |
| 93925 | Ultrasound study of arteries and arterial grafts of both legs | Office | 2021 | 19 | 19 | $9,428 | $3,679 | 39.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 22 | 22 | $5,670 | $2,837 | 50.0% |
| 99421 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | Office | 2021 | 20 | 201 | $5,820 | $2,326 | 40.0% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 58 | 58 | $3,411 | $2,244 | 65.8% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 92 | 92 | $3,216 | $1,765 | 54.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $8,843 | $1,700 | 19.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 38 | 43 | $4,730 | $1,459 | 30.8% |
| 93923 | Ultrasound study of arteries of both arms and legs, complete | Office | 2021 | 12 | 12 | $3,096 | $1,175 | 37.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $4,364 | $1,151 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 183 | 340 | $3,400 | $1,020 | 30.0% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 29 | 29 | $1,074 | $995.39 | 92.7% |
About Dr. Americo Baca, M.D
Dr. Americo Baca, M.D is a Family Medicine healthcare provider based in San Juan, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336168129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Americo Baca, M.D has received a total of $2,068 in payments from pharmaceutical and medical device companies, with $39.71 received in 2024. These payments were reported across 73 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,036).
As a Medicare-enrolled provider, Baca has provided services to 2,206 Medicare beneficiaries, totaling 4,325 services with total Medicare billing of $151,559. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location San Juan, TX
- Active Since 07/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336168129
Products in Payments
- BEVESPI AEROSPHERE (Drug) $527.27
- TRELEGY ELLIPTA (Drug) $292.97
- FORTEO (Drug) $202.89
- Tymlos (Biological) $186.21
- BREZTRI (Drug) $114.92
- FARXIGA (Drug) $109.99
- Orbactiv (Drug) $108.72
- BREO (Drug) $94.87
- LINZESS (Drug) $78.83
- ANORO ELLIPTA (Drug) $47.73
- ENTRESTO (Drug) $45.41
- INVOKANA (Drug) $39.92
- Kerendia (Drug) $39.71
- Peripheral Orbital Atherectomy System (Device) $32.72
- EMGALITY (Drug) $31.63
- VRAYLAR (Drug) $23.31
- TOUJEO (Drug) $20.56
- SYMBICORT (Drug) $17.59
- VERQUVO (Drug) $15.73
- TRULICITY (Drug) $13.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.